Asia-Pacific Is Expected To Create Lucrative Growth Opportunities For The Postbiotics Market

In Asia-Pacific, consumers have become increasingly concerned with their overall health. The COVID-19 pandemic has had a significant impact on this behavioral trait. However, consumers feel that their health has deteriorated in recent years. As a result, postbiotic products are being developed to boost health and nutrition. This is partly the result of an aging society and lifestyle and dietary concerns.

Further, according to BMC Gastroenterology, inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis have increased significantly across Asia-Pacific. According to the BMC Gastroenterology Journal, the prevalence of IBD in Asia-Pacific increased to 105 thousand cases in 2020 from 89.447 thousand cases in 2017. The cases are expected to increase to 183 thousand cases by 2035. A growing number of gastrointestinal diseases have also been reported in East Asian countries, including South Korea, Japan, and China, due to their modernization, adoption of Western dietary choices, and use of antibiotics widely.

Moreover, in China, the increasing consumer awareness about postbiotics and the growing development related to postbiotics is driving the country's growth. For instance, in May 2021, Lactobio A/S collaborated with its Chinese partner Vland Biotech Group to launch the postbiotic LB356R acne product in China. In the coming years, China will be a booming market for acne dermo-cosmetic products, with Chinese consumers becoming less price sensitive and willing to pay for branded products. Also, China’s health supplements market reached ~ RMB 271 billion in 2021 from RMB 128 billion in 2015 (Source: TMO Group). In 2021, the Chambio (Taiwanese firm) was expected to launch oral care, weight management, and immune health markets in China with heat-killed postbiotics to boost oral health and immunity. Hence, the increasing demand for health supplements in China is expected to boost the demand for postbiotics in the Asia-Pacific.

Also, the growing aging population in Japan is one of the main factors driving the sales of postbiotic supplements, followed by functional food and beverages. In Japan, postbiotics are available as both foods and drugs. For instance, in 2018, Morinaga Milk Industry got approval for Morinaga Milk’s LAC-Shield product, which is made from Lactobacillus paracasei MCC1849. Further, in 2021, House Wellness Foods (Japan) launched the product with heat-killed L-137 in their product lineups, including yogurt-flavored functional drinks, energy gel packs, and soluble powder for drinks and soup, among others.

Hence, the rising availability of postbiotic ingredients for applications in various areas, including dietary supplements and food & beverages, increasing consumer awareness about digestive health and benefits of postbiotics, and rising innovations in postbiotic formulations are the factors expected to create lucrative growth opportunities for the postbiotics market.

Meticulous Research^®, in its latest publication on the Global Postbiotics Market, states that the postbiotics market is projected to reach $24.0 million by 2029, at a CAGR of 10.1% during the forecast period 2022–2029.

Browse Report in Depth: https://www.meticulousresearch.com/product/postbiotics-market-5380